Beigene Ltd. (688235)
SSE
Closed
Sep 18, 2026
Day's Range
253.8552 wk Range
205.51Overview - 688235 - Beigene Ltd.
Key Statistics
Valuation
Enterprise Value
2.43T
P/E (Trailing)
‪85.57‬
P/E (Forward)
‪45.24‬
PEG Ratio
‪0.66‬
Price / Sales (TTM)
‪59.33‬
Price / Book
‪10.46‬
EV / EBITDA
‪338.26‬
Profitability
Gross Margin
‪89.76%‬
Profit Margin
‪10.69%‬
Operating Margin
‪19.06%‬
Return on Assets
‪7.45%‬
Return on Equity
‪14.66%‬
Ownership
Shares Outstanding
1.46B
Float
1.05B
Held by Insiders
‪2.57%‬
Held by Institutions
‪34.19%‬
Price stats
Beta
‪0.51‬
50-Day Avg
‪272.66‬
200-Day Avg
‪260.13‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Analyst Consensus
9 analysts
Average price target
‪CN¥ 364.41‬Market Cap - 688235 - Beigene Ltd.
Peers - 688235 - Beigene Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on SSE.
- 688235SSEBeigene Ltd.363.67BMarket Cap-29.40%52-week change85.57P/E (Trailing)‪10.69%‬Profit Margin
- 688331SSERemeGen Co., Ltd.64.73BMarket Cap+8.05%52-week change10.99P/E (Trailing)‪72.71%‬Profit Margin
- 688796SSEBiocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares53.41BMarket Cap+45.35%52-week change145.83P/E (Trailing)‪21.55%‬Profit Margin
- 688428SSEInnoCare Pharma Ltd.46.51BMarket Cap-4.22%52-week change54.78P/E (Trailing)‪33.04%‬Profit Margin
- 688578SSEShanghai Allist Pharmaceuticals Co., Ltd.44.77BMarket Cap-12.78%52-week change16.75P/E (Trailing)‪43.67%‬Profit Margin
- 688336SSESunshine Guojian Pharmaceutical Co., Ltd.34.11BMarket Cap+0.89%52-week change11.10P/E (Trailing)‪69.64%‬Profit Margin
- 603392SSEBeijing Wantai Biological Pharmacy Enterprise Co., Ltd.33.22BMarket Cap-124.77%52-week change826.25P/E (Trailing)‪-18.90%‬Profit Margin
Profile Summary - 688235 - Beigene Ltd.
About
Beigene Ltd. is a global biotechnology company dedicated to developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. The company is heavily involved in the discovery and development of novel therapeutics, focusing particularly on the design of small…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
